Adagrasib side effects
Adagrasib (Adagrasib) is a targeted therapy for patients with KRAS G12C mutated non-small cell lung cancer. Its therapeutic effect brings hope. However, like many drugs, it may also be accompanied by a series of side effects. The possible side effects of adagrasiib will be discussed in detail below so that patients can more fully understand and work closely with their doctors during use to ensure the best therapeutic effect.
Digestive system side effects:
1.Nausea and Vomiting: Some patients may experience mild to moderate nausea and vomiting after taking adagrasib. These symptoms are usually temporary, but if they are severe or prolonged, patients should report them to their doctor promptly.
2.Diarrhea: Adagrasib may cause diarrhea, which may have a certain impact on the patient's quality of life. Your doctor may recommend steps to relieve this symptom, such as dietary changes or medication support.
Skin and mucous membrane side effects:
1.Skin rash: Skin rash is one of the more common side effects of adagrasiib. Patients may experience symptoms such as skin erythema, itching, or dryness. These symptoms are usually mild, but your doctor should be notified when noticed so that appropriate treatment can be taken promptly.
2.Dryness and flaking: Some patients may experience dryness and flaking of the skin. Keeping your skin properly moisturized may help reduce these symptoms.
Abnormal liver function:
Elevated aminotransferases: The use of adagrasib may lead to an increase in liver function indicators such as AST (aspartate aminotransferase) and ALT (alanine aminotransferase). Regular monitoring of liver function is an important step in the treatment process to detect and deal with potential problems in a timely manner.

Eye side effects:
1.Dry eyes: Some patients may experience dryness and discomfort in their eyes, which may be related to the use of adagrasib. Using artificial tears or other eye care products may help reduce this symptom.
2.Visual problems: Although rare, adagrasib use may be associated with some visual problems, such as blurring or eye pain. Patients should promptly report these problems to their doctor when they discover them.
Other side effects:
1.Fatigue: During the use of adagrasib, some patients may experience fatigue and a feeling of weakness. This may require patients to rest and adjust their activity levels during treatment.
2.Fever: Some patients may experience fever after taking adagrasib. In this case, the patient should report it to the doctor promptly to determine whether further evaluation and treatment are needed.
Warnings and Precautions:
1.Pneumonia risk: Using adagrasib may increase the patient's risk of pneumonia. Patients should pay close attention to respiratory symptoms during treatment and report to the doctor in time.
2.Liver function monitoring: Regular monitoring of liver function is a necessary step when using adagrasib to ensure the patient's liver health.
3.Eye monitoring: Perform regular eye examinations to identify and treat potential eye problems in a timely manner.
4.Pregnant and breastfeeding women: Pregnant and breastfeeding women should consult a doctor before using adagrasib because the drug may cause damage to the fetus.
The side effects of adagrasib are mainly manifested in the digestive system, skin and mucous membranes, liver function, eyes and some general discomfort symptoms. Patients should promptly report any symptoms of discomfort to the doctor during use so that the doctor can take appropriate measures. During treatment, doctors will closely monitor the patient's overall condition, adjust the treatment plan to ensure the best treatment effect, and minimize the impact of side effects on the patient's quality of life. Maintaining communication between patients and doctors is key to ensuring successful treatment.
Adagrasib is not currently available in the country, so patients cannot purchase it domestically and can only purchase adagrasib through overseas channels. Abroad, there is only the original American drug adagrasib, and the price is very high, as high as about 190,000 yuan.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)